Literature DB >> 33914478

Utilization Trends and Volume-Outcomes Relationship of Endoscopic Resection for Early Stage Esophageal Cancer.

Nicole G Jawitz1, Vignesh Raman, Oliver K Jawitz, Rahul A Shimpi, Richard K Wood, Matthew G Hartwig, Thomas A D'Amico.   

Abstract

OBJECTIVES: We describe utilization trends and center volume-outcomes relationship of endoscopic resection of early stage esophageal cancer using a large hospital-based registry. SUMMARY BACKGROUND DATA: Endoscopic resection is increasingly accepted as the preferred treatment for early stage esophageal cancer, however its utilization and the center volume-outcomes relationship in the United States is unknown.
METHODS: The National Cancer Database was used to identify patients with cT1N0M0 esophageal cancer treated with endoscopic resection or esophagectomy between 2004 and 2015. Relative frequencies were plotted over time. Restricted cubic splines and maximally selected rank statistics were used to identify an inflection point of center volume and survival.
RESULTS: 1136 patients underwent ER and 2829 patients underwent esophagectomy during the study period. Overall utilization of ER, as well as relative use compared to esophagectomy, increased throughout the study period. Median annualized center ER volume was 1.9 cases per year (IQR 0.5-5.8). Multivariable Cox regression showed increasing annualized center volume by one case per year was associated with improved survival. Postoperative 30- or 90-day mortality, 30-day readmission, and pathologic T upstaging rates were similar irrespective of center volume.
CONCLUSIONS: Utilization of ER compared to esophagectomy for stage I esophageal cancer has increased over the past decade, though many individual centers perform fewer than 1 case annually. Increasing annualized center volume by one procedure per year was associated with improved survival. Increased volume beyond this was not associated with survival benefit. Referral to higher volume centers for treatment of superficial esophageal cancer should be considered.

Entities:  

Year:  2021        PMID: 33914478      PMCID: PMC8966412          DOI: 10.1097/SLA.0000000000004834

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   13.787


  16 in total

1.  Systematic review and a meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery.

Authors:  Ya Ruth Huo; Kevin Phan; David L Morris; Winston Liauw
Journal:  J Gastrointest Oncol       Date:  2017-06

2.  Technical feasibility and oncologic safety of diagnostic endoscopic resection for superficial esophageal cancer.

Authors:  Masashi Takeuchi; Koichi Suda; Yasuo Hamamoto; Motohiko Kato; Shuhei Mayanagi; Kayo Yoshida; Kazumasa Fukuda; Rieko Nakamura; Norihito Wada; Hirofumi Kawakubo; Hiroya Takeuchi; Naohisa Yahagi; Yuko Kitagawa
Journal:  Gastrointest Endosc       Date:  2018-05-08       Impact factor: 9.427

3.  Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  F Lordick; C Mariette; K Haustermans; R Obermannová; D Arnold
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

Review 4.  Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus.

Authors:  Patrick E Young; Andrew B Gentry; Ruben D Acosta; Bruce D Greenwald; Mark Riddle
Journal:  Clin Gastroenterol Hepatol       Date:  2010-09-08       Impact factor: 11.382

Review 5.  Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000-2011.

Authors:  Sheraz R Markar; Alan Karthikesalingam; Sri Thrumurthy; Donald E Low
Journal:  J Gastrointest Surg       Date:  2011-11-17       Impact factor: 3.452

6.  A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data.

Authors:  Ananya Das; Vandana Singh; David E Fleischer; Virender K Sharma
Journal:  Am J Gastroenterol       Date:  2008-05-28       Impact factor: 10.864

7.  Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection.

Authors:  Darren D Ballard; Neel Choksi; Jingmei Lin; Eun-Young Choi; B Joseph Elmunzer; Henry Appelman; Douglas K Rex; Hala Fatima; William Kessler; John M DeWitt
Journal:  World J Gastrointest Endosc       Date:  2016-12-16

8.  The influence of procedural volume and proficiency gain on mortality from upper GI endoscopic mucosal resection.

Authors:  Sheraz R Markar; Hugh Mackenzie; Melody Ni; Jeremy R Huddy; Alan Askari; Omar Faiz; S Michael Griffin; Laurence Lovat; George B Hanna
Journal:  Gut       Date:  2016-10-18       Impact factor: 23.059

9.  Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma?: A Propensity-matched Analysis.

Authors:  Sivesh K Kamarajah; Alexander W Phillips; George B Hanna; Donald E Low; Sheraz R Markar
Journal:  Ann Surg       Date:  2022-04-01       Impact factor: 12.969

10.  The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.

Authors:  Karl Y Bilimoria; Andrew K Stewart; David P Winchester; Clifford Y Ko
Journal:  Ann Surg Oncol       Date:  2008-01-09       Impact factor: 5.344

View more
  1 in total

1.  Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer.

Authors:  Fei Lin; Li-Ping Zhang; Shuang-Yan Xie; Han-Ying Huang; Xiao-Yu Chen; Tong-Chao Jiang; Ling Guo; Huan-Xin Lin
Journal:  Front Oncol       Date:  2022-04-13       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.